Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 Bekeken
• 07/08/23
0
0
insluiten
administrator
abonnees
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties